产品编号 :
Cas No. :
CAS No. |
103222-11-3 |
|---|---|
中文名称 |
13-((1H-吲哚-3-基)甲基)-N-(1-氨基-3-(1H-吲哚-3-基)-1-氧代丙烷-2-基)-19-(2-氨基-3-苯基丙酰胺基)-10-(4-氨基丁基)-16-(4-羟基苄基)-7-(丙烷-2-基)-6,9,12,15,18-五氧代-1,2-二硫杂-5,8,11,14,17-五氮杂环二十烷-4-甲酰胺 |
英文名称 |
13-((1H-indol-3-yl)methyl)-N-(1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl)-19-(2-amino-3-phenylpropanamido)-10-(4-aminobutyl)-16-(4-hydroxybenzyl)-7-isopropyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide |
别名 |
D-Phe-Cys-Tyr-D-Trp-Lys-Val-Cys-Trp-NH2 (Disulfide bridge Cys2-Cys7);H-D-Phe-Cys-Tyr-D-Trp-Lys-Val-Cys-Trp-NH2;D-Phe-Cys-Trp-D-Trp-Lys-Val-Cys-Trp-CONH2(disulfide Cys2-Cys7);Vapreotide, RC-160;RC-160;VAPREOTIDE;D-PHE-CYS-TYR-D-TRP-LYS-VAL-CYS-TRP-NH2;FCYWKVCW-NH2 |
标准英文名 |
13-((1H-indol-3-yl)methyl)-N-(1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl)-19-(2-amino-3-phenylpropanamido)-10-(4-aminobutyl)-16-(4-hydroxybenzyl)-7-isopropyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide |
分子式 |
C57H70N12O9S2 |
分子量 |
1131.40 |
精确分子量 |
1130.48 |
SMILES |
CC(C)C1NC(=O)C(CCCCN)NC(=O)C(CC2=CNC3=CC=CC=C23)NC(=O)C(CC2=CC=C(O)C=C2)NC(=O)C(NC(=O)C(N)CC2=CC=CC=C2)CSSCC(C(=O)NC(CC2=CNC3=CC=CC=C23)C(N)=O)NC1=O |
标准SMILES |
CC(C)C1NC(=O)C(CCCCN)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(CC2=CC=C(O)C=C2)NC(=O)C(CSSCC(NC1=O)C(=O)NC(CC1=CNC2=CC=CC=C12)C(N)=O)NC(=O)C(N)CC1=CC=CC=C1 |
用途 |
Treatment of acute esophageal variceal bleeding (EVB); hemostasis prior to endoscopic intervention; prevention of rebleeding within 5 days after endoscopic therapy; potential treatment for prostate cancer and acromegaly; targeted radiotherapy for certain gastroenteropancreatic (GEP) tumors using radiolabeled vapreotide. |
InChIKey |
SWXOGPJRIDTIRL-UHFFFAOYSA-N |
|
|
评论 |
|---|